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Background/Introduction
High-risk patients with multivessel disease (MVD)
represent a surgical challenge carrying high mortality
risk. These cases elicit discussion within heart teams
regarding the actual benefit of undertaking major sur-
gery on these patients and often lead to abandon the
surgical option. Off-pump coronary artery bypass
(OPCAB) provides good quality graft on left anterior
descending (LAD) without exposing the patient to cardi-
opulmonary bypass, and, despite providing an incom-
plete revascularization, might be the ideal choice in
patients with multiple comorbidities, not eligible to per-
cutaneous or on-pump procedures.
Aims/Objectives
To compare survival in high-risk patients with MVD
and no percutaneous option, treated with incomplete
off-pump surgical myocardial revascularization or dis-
charged on optimal medical therapy.
Method
83 high-risk patients with MVD were enrolled: 42 were
treated with incomplete off-pump revascularization
using left internal mammary artery (LIMA) to LAD; 41
were treated with optimal medical therapy (OMT), hav-
ing refused surgery. Patients were followed-up by
telephone interview. Primary endpoint was survival from
all-cause mortality; secondary endpoints were survival
from cardiac-related mortality and freedom from non-
fatal major adverse cardiac events (MACE).
Results
During follow up, there were 11 deaths in OPCAB
group and 27 deaths in OMT group. Death was due to
cardiac factors in 6 and 15 patients, respectively.
MACEs were observed in 6 patients in OPCAB group
and 4 patients in OMT group. Both survival from all-
cause mortality and cardiac-related events were in favor
of the OPCAB group over the OMT which carried a
propensity score-adjusted hazard ratio of 3.862 and
3.663, for all-cause and cardiac-related mortality respec-
tively. There was no statistically significant difference
concerning freedom from MACE.
Discussion/Conclusion
For high-risk patients with MVD, considered ineligible
for on-pump complete revascularization surgery or per-
cutaneous coronary intervention, incomplete revasculari-
zation with OPCAB LIMA-on-LAD offers benefits in
survival when compared to OMT alone.
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